Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

PRAX Praxis Precision Medicines Inc

71,76

-5,12 (-6,66%)

16 Nov 2024 - Fermé

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/14/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Lauren M Mastrocola

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Praxis Precision Medicines (NASDAQ:PRAX)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024

Plus de graphiques de la Bourse Praxis Precision Medicines

Praxis Precision Medicines (NASDAQ:PRAX)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024

Plus de graphiques de la Bourse Praxis Precision Medicines

Actualités Praxis Precision Medicines Inc

Form 4 - Statement of changes in beneficial ownership of securities
Samedi 16 Novembre 2024 ( il y a 1 jour) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samedi 16 Novembre 2024 ( il y a 1 jour) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jeudi 14 Novembre 2024 ( il y a 2 jours) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jeudi 14 Novembre 2024 ( il y a 2 jours) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jeudi 14 Novembre 2024 ( il y a 2 jours) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Vendredi 8 Novembre 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mercredi 6 Novembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 8-K - Current report
Mercredi 6 Novembre 2024 ( il y a 2 semaines) • Edgar (US Regulatory)

Form 8-K - Current report
Mardi 15 Octobre 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Praxis Precision Medicines presents on ulixacaltamide Essential3 program at the Movement Disorders Society 2024 International Congress
Jeudi 26 Septembre 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Form 8-K - Current report
Mardi 3 Septembre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mardi 13 Août 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Plus d'articles sur Praxis Precision Medicines Inc

Credit Agricole

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales